IRIS
CHIEFFO, ALAIDE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 597
NA - Nord America 591
AS - Asia 67
SA - Sud America 6
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.264
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 586
SE - Svezia 389
IT - Italia 100
CN - Cina 35
IE - Irlanda 32
FI - Finlandia 26
DE - Germania 15
GB - Regno Unito 14
IR - Iran 8
RU - Federazione Russa 8
HK - Hong Kong 7
PL - Polonia 7
CA - Canada 5
BR - Brasile 4
IN - India 4
SG - Singapore 4
TR - Turchia 3
DK - Danimarca 2
ES - Italia 2
IQ - Iraq 2
TH - Thailandia 2
TN - Tunisia 2
AR - Argentina 1
EU - Europa 1
FR - Francia 1
HU - Ungheria 1
KR - Corea 1
PH - Filippine 1
UY - Uruguay 1
Totale 1.264
Salva come PNG Salva come JPEG
Città #
Lawrence 149
Princeton 149
New York 58
Milan 51
Ashburn 37
Dublin 32
Shanghai 27
Helsinki 24
Seattle 15
Rome 7
Los Angeles 5
Krakow 4
Tianjin 4
Washington 4
Ankara 3
Borås 3
Edinburgh 3
Edmonton 3
Hanover 3
Loano 3
Mikołów 3
Bangkok 2
Bari 2
Bethesda 2
Castenaso 2
Copenhagen 2
Gatchina 2
Hong Kong 2
Lappeenranta 2
Mascalucia 2
Moscow 2
Pistoia 2
Rockville 2
São Paulo 2
Torre del Lago Puccini 2
Vadodara 2
Arezzo 1
Aurora 1
Bene Vagienna 1
Buenos Aires 1
Chandler 1
Cheyenne 1
Council Bluffs 1
Dalsjoefors 1
Dzerzhinsk 1
Earls Court 1
Gavirate 1
Guangzhou 1
Gurgaon 1
Islington 1
Makati City 1
Modena 1
Montevideo 1
Montreal 1
Mountain View 1
Nam-gu 1
Napoli 1
Novara 1
Omsk 1
Padova 1
Pisa 1
Pune 1
Raleigh 1
Rende 1
Santa Clara 1
Sesto San Giovanni 1
Singapore 1
Southwark 1
Springfield 1
St Petersburg 1
Tehran 1
Temecula 1
Toronto 1
Totale 654
Salva come PNG Salva come JPEG
Nome #
A systematic transoesophageal echocardiography study of suture-mediated percutaneous patent foramen ovale closure 32
A "modified crossover technique" for vascular access management in high-risk patients undergoing transfemoral transcatheter aortic valve implantation 23
Prognostic impact of mitral regurgitation changes after TAVI 22
Ultrasound-assisted thrombolysis in high and intermediate-high risk pulmonary embolism patients with contraindications to systemic thrombolysis: a retrospective multicentre experience 21
Analysis of a Low Dose Protocol to Reduce Patient Radiation Exposure During Percutaneous Coronary Interventions 19
Interatrial Septal Tear After Patent Foramen Ovale Closure With the NobleStitch Device 18
Impact of Ascending Aorta Dilation on Mid-Term Outcome After Transcatheter Aortic Valve Implantation 18
5-year outcomes following percutaneous coronary intervention with drug-eluting stent implantation versus coronary artery bypass graft for unprotected left main coronary artery lesions the Milan experience 17
A challenging case of transcatheter aortic prosthesis dysfunction: Endocarditis or thrombosis? 17
A Comparison of the Femoral and Radial Crossover Techniques for Vascular Access Management in Transcatheter Aortic Valve Implantation: The Milan Experience 17
Anticoagulation for Percutaneous Ventricular Assist Device-Supported Cardiogenic Shock: JACC Review Topic of the Week 16
A complex valve anatomy for mitraclip: Forme fruste of Barlow’s disease with cleft 16
ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2-care pathways, treatment, and follow-up 15
A Comparison Between New Generation And First Generation Transcatheter Aortic Valve Implantation (TAVI) Devices: A Single Centre Experience 14
Does the STS-PROM Score or the Logistic EuroSCORE Predict Outcomes Following Transcatheter Aortic Valve Replacement at 30 Days: the Milan Experience 14
A novel supra-annular plane that predicts TAVI prosthesis anchoring in raphe-type bicuspid aortic valve disease: the LIRA plane 13
Sex Differences in Use of Intracoronary Imaging in Patients Undergoing Percutaneous Coronary Intervention 13
Frequency of slow coronary flow following successful stent implantation and effect of Nitroprusside 13
Antigen-driven evolution of B lymphocytes in coronary atherosclerotic plaques 13
A Comparison Between First-Generation and Second-Generation Transcatheter Aortic Valve Implantation (TAVI) Devices: A Propensity-Matched Single-Center Experience 13
A comparison of the fully repositionable and retrievable Boston Lotus and direct flow medical valves for the treatment of severe aortic stenosis: A single center experience 13
Impact of Post-Percutaneous Coronary Intervention Fractional Flow Reserve Measurement on Procedural Management and Clinical Outcomes: The REPEAT-FFR Study 12
Impact of Left Ventricular Outflow Tract Calcification on Pacemaker Implantation After Transcatheter Aortic Valve Implantation With Second-Generation Devices 12
Need for permanent pacemaker implantation after corevalve, sapien and surgical aortic valve replacement: incidence, time course and predictive factors 12
Mid-term clinical outcomes after bailout drug-eluting stenting for suboptimal drug-coated balloon results: Insights from a Milan registry 11
Coronary Protection to Prevent Coronary Obstruction During TAVR 11
Transcatheter aortic bioprosthesis durability: A single center experience 11
Drug eluting stent implantation versus bypass surgery in unprotected left stenosis: A single center experience 11
A comparison Of The Femoral And Radial Crossover Techniques For Vascular Access Management In Transcatheter Aortic Valve Implantation: The Milan Experience 11
Radial Versus Femoral Access for the Treatment of Left Main Lesion in the Era of Second-Generation Drug-Eluting Stents 11
Tricento Transcatheter Heart Valve for Severe Tricuspid Regurgitation: Procedural Planning and Technical Aspects 11
Self-expanding transcatheter aortic valve infolding: Current evidence, diagnosis, and management 11
A High Dose of Adenosine to Induce Transient Asystole for Valvuloplasty in Patients Undergoing Transcatheter Aortic Valve Implantation (TAVI): Is it a Valid Alternative to Rapid Pacing? A Prospective Pilot Study 11
Sex and Transcatheter Aortic Valve Implantation: Impact of Female Sex on Clinical Outcomes 10
Computing Methods for Composite Clinical Endpoints in Unprotected Left Main Coronary Artery Revascularization: A Post Hoc Analysis of the DELTA Registry 10
FEVER AFTER TAVI (TRANSCATHETER AORTIC VALVE IMPLANTATION): IS IT INFLAMMATION OR INFECTION? 10
A New Tool to Manage Side-Branch Occlusion After Covered-Stent Implantation for Vascular Complications The Neocarina Reconstruction Technique 10
Levelling the field of cardiovascular disease in women 9
STEMIs and a Closer Look at MINOCA During the COVID-19 Pandemic 9
Heyde's Syndrome Incidence and Outcome in Patients Undergoing Transcatheter Aortic Valve Implantation 9
Trascatheter Aortic Valve Implantation Outcomes With Self-Expandable and Balloon-Expandable Devices in Patients with Mixed Aortic Valve Stenosis 9
Preliminary outcomes after transcatheter aortic valve implantation in patients with systemic sclerosis 9
Outcomes after transcatheter aortic valve implantation with both Edwards-SAPIEN and CoreValve devices in a single center: the Milan experience 9
Managing Patients With an Indication for Anticoagulant Therapy After Transcatheter Aortic Valve Implantation 9
Incidence and Management of Restenosis After Treatment of Unprotected Left Main Disease With Second-Generation Drug-Eluting Stents (from Failure in Left Main Study With 2nd Generation Stentsâ Cardiogroup III Study) 9
Radiation exposure and contrast agent reduction during transcatheter aortic valve implantation: An ongoing experience 9
Impact of Mitral Annular Calcium on Outcomes after Transcatheter Aortic Valve Implantation 9
Percutaneous exclusion of left ventricular pseudoaneurysm 9
Mid-Term Clinical Outcomes Following Percutaneous Mitral Valve Edge-to-Edge Repair 9
Drug eluting stent implantation versus bypass surgery in unprotected left main stenosis: A single center experience 9
ST-Elevation Myocardial Infarction in Patients With COVID-19: Clinical and Angiographic Outcomes 9
"Procedural trauma risks longitudinal shortening of the Promus Element™ stent platform" 8
Impact of Clinical and Lesion Features on Outcomes After Percutaneous Coronary Intervention in Bifurcation Lesions 8
Preliminary observations regarding angiographic pattern of restenosis after rapamycin-eluting stent implantation 8
Impella RP for Patients with Acute Right Ventricular Failure and Cardiogenic Shock: A Subanalysis from the IMP-IT Registry 8
Observational Multicenter Registry of Patients Treated with IMPella Mechanical Circulatory Support Device in ITaly: The IMP-IT Registry 8
Five Year Outcomes Following PCI with DES Implantation vs CABG for Unprotected Left Main Coronary Artery Lesions: Milan Experience 8
To predilate or to not predilate in transcatheter aortic valve implantation? Single-center experience with self-expandable devices 8
Long-term outcomes after transcatheter aortic valve implantation from a single high-volume center (The Milan Experience) 8
Provisional versus elective two-stent strategy for unprotected true left main bifurcation lesions: Insights from a FAILS-2 sub-study 8
Causes, Timing, and Impact of Dual Antiplatelet Therapy Interruption for Surgery (from the Patterns of Non-adherence to Anti-platelet Regimens In Stented Patients Registry) 8
Percutaneous transjugular tricuspid valve-in-valve implantation for degenerated surgical bioprosthetic valve 8
Comparison of Percutaneous Coronary Intervention (With Drug-Eluting Stents) Versus Coronary Artery Bypass Grafting in Women With Severe Narrowing of the Left Main Coronary Artery (from the Women-Drug-Eluting stent for LefT main coronary Artery disease Registry) 8
Incidence, Management, and Outcomes of Cardiac Tamponade During Transcatheter Aortic Valve Implantation A Single-Center Study 8
Rate of progression of ascending aorta dilatation in patients with bicuspid and tricuspid aortic valve 8
Predictors of Advanced Conduction Disturbances Requiring a Late (≥48 H) Permanent Pacemaker Following Transcatheter Aortic Valve Replacement 8
Corrigendum: “Long-Term (≥10 Years) Safety of Percutaneous Treatment of Unprotected Left Main Stenosis With Drug-Eluting Stents” (The American Journal of Cardiology 118 (2016) (32–39), (S000291491630488X), (10.1016/j.amjcard.2016.04.007)) 7
Real-Time Intravascular Ultrasound Guidance for Ultra-Low Contrast Complex Bifurcation Percutaneous Coronary Intervention 7
17-beta-estradiol eluting stent versus phosphorylcholine-coated stent for the treatment of native coronary artery disease 7
The impact of chronic kidney disease severity on clinical outcomes after current generation drug-eluting stent implantation for left main distal bifurcation lesions: the Milan and New-Tokyo registry 7
European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis 7
Polymer-Free Biolimus-Eluting Stents or Polymer-Based Zotarolimus-Eluting Stents for Coronary Bifurcation Lesions 7
Emergency stenting for stroke after carotid endarterectomy. 7
Successful percutaneous anterograde transcatheter valve-in-valve implantation in the mitral position 7
Predictors of moderate-to-severe paravalvular aortic regurgitation immediately after CoreValve implantation and the impact of postdilatation 7
Early Outcomes With Direct Flow Medical Versus 1 degrees-Generation Transcatheter Aortic Valve Devices: A Single-Center Propensity-Matched Analysis 7
Single-Antiplatelet Therapy in Patients with Contraindication to Dual-Antiplatelet Therapy After Transcatheter Aortic Valve Implantation 7
Bioresorbable Vascular Scaffolds and Very Late Scaffold Thrombosis: Searching an Explanation and a Solution 7
Comparison of paclitaxel drug-eluting balloon and paclitaxel-eluting stent in small coronary vessels in diabetic and nondiabetic patients â results from the BELLO (balloon elution and late loss optimization) trial 7
Incidence, Patterns, and Associations Between Dual-Antiplatelet Therapy Cessation and Risk for Adverse Events Among Patients With and Without Diabetes Mellitus Receiving Drug-Eluting Stents: Results From the PARIS Registry 7
OUTCOMES FOLLOWING TRANSCATHETER AORTIC VALVE IMPLANTATION COMPARING EDWARDS SAPIEN WITH MEDTRONIC COREVALVE REVALVING SYSTEM DEVICES: RESULTS FROM THE MILAN REGISTRY 7
Five Year Outcomes Following Drug-eluting Stents Implantation vs. Coronary Artery Bypass Graft Surgery for Unprotected Left Main Coronary Artery Lesions: Milan Experience 7
Bleeding-Related Deaths in Relation to the Duration of Dual-Antiplatelet Therapy After Coronary Stenting 7
Predictors of cardiac death in patients with coronary chronic total occlusion not revascularized by PCI 7
Comparison of Results of Transcatheter Aortic Valve Implantation in Patients With Severely Stenotic Bicuspid Versus Tricuspid or Nonbicuspid Valves 7
Response to letters regarding article, "Percutaneous treatment with drug-eluting stent implantation versus bypass surgery for unprotected left main stenosis: A single-center experience" 7
Quality of life improvement is maintained up to two years after transcatheter aortic valve implantation in high-risk surgical candidates 7
Usefulness of Predilation Before Transcatheter Aortic Valve Implantation 7
Early outcomes with direct flow medical versus first-generation transcatheter aortic valve devices: A single-center propensity-matched analysis 7
A novel approach to chronic total occlusions: the crosser system 7
Bleeding risk differences after TAVR according to the ARC-HBR criteria: insights from SCOPE 2 6
Coronary Vasomotor Disorders: One Size Does Not Fit All 6
Sex-Specific Considerations in Degenerative Aortic Stenosis for Female-Tailored Transfemoral Aortic Valve Implantation Management 6
Outcomes in Patients With Early Menopause Who Underwent Transcatheter Aortic Valve Implantation 6
Angiographic analysis of pattern of late luminal loss in sirolimus- and paclitaxel-eluting stents 6
null 6
Provisional Strategy for Left Main Stem Bifurcation Disease: A State-of-the-Art Review of Technique and Outcomes 6
European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1 - epidemiology, pathophysiology, and diagnosis 6
Transcatheter aortic valve implantation using the ACURATE neo in bicuspid and tricuspid aortic valve stenosis: a propensity-matched analysis of a European experience 6
Emergency department cardiovascular disease encounters and associated mortality in patients with cancer: A study of 20.6 million records from the USA 6
Totale 1.006
Salva come PNG Salva come JPEG
Categoria #
all - tutte 33.094
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.094
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202012 2 0 0 5 3 0 0 0 0 2 0 0
2020/202122 0 0 0 4 0 16 1 0 1 0 0 0
2021/202279 0 0 0 40 4 2 6 7 5 0 4 11
2022/2023964 328 170 45 5 2 83 35 46 18 10 14 208
2023/2024519 124 41 84 38 53 86 6 49 16 15 7 0
Totale 1.649